AEON Biopharma (AEON) Institutional Ownership $0.56 -0.02 (-3.43%) (As of 11/20/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for AEON Biopharma (NASDAQ:AEON)CurrentInstitutional OwnershipPercentage22.78%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$6.52MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$10.80M Get AEON Insider Trade Alerts Want to know when executives and insiders are buying or selling AEON Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AEON Institutional Buying and Selling by Quarter Ad DTIWhen it comes to NVDA… “acceleration cycles” are the keyExpert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.Use this link to see Nvidia Unchained right away! AEON Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC243,168$255K0.0%+30.1%0.622% 11/15/2024 Polar Asset Management Partners Inc.3,599,918$3.78M0.1%-2.0%9.202% 11/15/2024 HighTower Advisors LLC23,776$25K0.0%N/A0.061% 11/7/2024 Caprock Group LLC62,686$66K0.0%N/A0.160% 8/14/2024 Davidson Kempner Capital Management LP90,053$95K0.0%-75.4%0.230% 5/17/2024 Shaolin Capital Management LLC21,380$248K0.0%-97.7%0.057% 5/10/2024 Vanguard Group Inc.758,992$8.80M0.0%+261.8%2.008% 2/7/2024 Formidable Asset Management LLC58,193$419K0.1%-9.5%0.157% 11/9/2023 Formidable Asset Management LLC64,311$360K0.1%N/A0.723% 11/6/2023Atalaya Capital Management LP3,675,000$19.83M21.7%N/A41.283% (Data available from 1/1/2016 forward) AEON Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AEON shares? During the previous two years, 9 institutional investors and hedge funds held shares of AEON Biopharma. The most heavily invested institutionals were Atalaya Capital Management LP ($19.83M), Vanguard Group Inc. ($8.80M), Polar Asset Management Partners Inc. ($3.78M), Formidable Asset Management LLC ($419K), Geode Capital Management LLC ($255K), Shaolin Capital Management LLC ($248K), and Davidson Kempner Capital Management LP ($95K).Learn more on AEON's institutional investors. What percentage of AEON Biopharma stock is owned by institutional investors? 22.78% of AEON Biopharma stock is owned by institutional investors. Learn more on AEON's institutional investor holdings. Which institutional investors have been buying AEON Biopharma stock? The following institutional investors have purchased AEON Biopharma stock in the last 24 months: Atalaya Capital Management LP ($3.68M), Vanguard Group Inc. ($549.21K), Formidable Asset Management LLC ($64.31K), Caprock Group LLC ($62.69K), Geode Capital Management LLC ($56.31K), and HighTower Advisors LLC ($23.78K). How much institutional buying is happening at AEON Biopharma? Institutional investors have bought a total of 4,431,290 shares in the last 24 months. This purchase volume represents approximately $27.46M in transactions. Which AEON Biopharma major shareholders have been selling company stock? The following institutional investors have sold AEON Biopharma stock in the last 24 months: Shaolin Capital Management LLC ($895.74K), Davidson Kempner Capital Management LP ($276.62K), Polar Asset Management Partners Inc. ($75.08K), and Formidable Asset Management LLC ($6.12K). How much institutional selling is happening at AEON Biopharma? Institutional investors have sold a total of 1,253,558 shares in the last 24 months. This volume of shares sold represents approximately $10.80M in transactions. Related Companies ASRT Major Shareholders RLMD Major Shareholders ANVS Major Shareholders GNLX Major Shareholders ACET Major Shareholders ME Major Shareholders ALLK Major Shareholders CASI Major Shareholders FBLG Major Shareholders PMVP Major Shareholders This page (NASDAQ:AEON) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AEON Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AEON Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
